Switch theme
Sign up to access all valuation multiples
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship products are Provet Cloud and EasyPractice, both cloud-based Practice Management Software for veterinarians and therapists, respectively. It builds software that empowers healthcare professionals to improve patient care, increase efficiency and expand their business. The company has two operating segments namely: Veterinary and Therapy. It operates geographically in Norway, which derives maximum revenue, Finland, the United Kingdom, Sweden, Denmark, Germany and Other countries.
2021
411
LTM Revenue $592M
LTM EBITDA $44.9M
$268M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nordhealth has a last 12-month revenue (LTM) of $592M and a last 12-month EBITDA of $44.9M.
In the most recent fiscal year, Nordhealth achieved revenue of $4.5M and an EBITDA of $0.4M.
Nordhealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nordhealth valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $592M | XXX | $4.5M | XXX | XXX | XXX |
| Gross Profit | $500M | XXX | $3.8M | XXX | XXX | XXX |
| Gross Margin | 84% | XXX | 85% | XXX | XXX | XXX |
| EBITDA | $44.9M | XXX | $0.4M | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 9% | XXX | XXX | XXX |
| EBIT | -$92.1M | XXX | -$0.8M | XXX | XXX | XXX |
| EBIT Margin | -16% | XXX | -17% | XXX | XXX | XXX |
| Net Profit | -$97.3M | XXX | -$0.8M | XXX | XXX | XXX |
| Net Margin | -16% | XXX | -17% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Nordhealth's stock price is NOK 38 (or $4).
Nordhealth has current market cap of NOK 3.0B (or $294M), and EV of NOK 2.7B (or $268M).
See Nordhealth trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $268M | $294M | XXX | XXX | XXX | XXX | $-0.01 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Nordhealth has market cap of $294M and EV of $268M.
Nordhealth's trades at 60.0x EV/Revenue multiple, and 650.7x EV/EBITDA.
Equity research analysts estimate Nordhealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nordhealth has a P/E ratio of -34.7x.
See valuation multiples for Nordhealth and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $294M | XXX | $294M | XXX | XXX | XXX |
| EV (current) | $268M | XXX | $268M | XXX | XXX | XXX |
| EV/Revenue | 5.2x | XXX | 60.0x | XXX | XXX | XXX |
| EV/EBITDA | 68.7x | XXX | 650.7x | XXX | XXX | XXX |
| EV/EBIT | -33.4x | XXX | -355.0x | XXX | XXX | XXX |
| EV/Gross Profit | 6.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | -34.7x | XXX | -391.5x | XXX | XXX | XXX |
| EV/FCF | -1768.6x | XXX | -864.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNordhealth's last 12 month revenue growth is 22%
Nordhealth's revenue per employee in the last FY averaged $11K, while opex per employee averaged $11K for the same period.
Nordhealth's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nordhealth's rule of X is 62% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nordhealth and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 22% | XXX | 290% | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Growth | 76% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 20% | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 62% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $11K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $11K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 102% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nordhealth acquired XXX companies to date.
Last acquisition by Nordhealth was XXXXXXXX, XXXXX XXXXX XXXXXX . Nordhealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Nordhealth founded? | Nordhealth was founded in 2021. |
| Where is Nordhealth headquartered? | Nordhealth is headquartered in Norway. |
| How many employees does Nordhealth have? | As of today, Nordhealth has 411 employees. |
| Is Nordhealth publicy listed? | Yes, Nordhealth is a public company listed on OSL. |
| What is the stock symbol of Nordhealth? | Nordhealth trades under NORDH ticker. |
| When did Nordhealth go public? | Nordhealth went public in 2021. |
| Who are competitors of Nordhealth? | Similar companies to Nordhealth include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Nordhealth? | Nordhealth's current market cap is $294M |
| What is the current revenue of Nordhealth? | Nordhealth's last 12 months revenue is $592M. |
| What is the current revenue growth of Nordhealth? | Nordhealth revenue growth (NTM/LTM) is 22%. |
| What is the current EV/Revenue multiple of Nordhealth? | Current revenue multiple of Nordhealth is 5.2x. |
| Is Nordhealth profitable? | Yes, Nordhealth is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nordhealth? | Nordhealth's last 12 months EBITDA is $44.9M. |
| What is Nordhealth's EBITDA margin? | Nordhealth's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Nordhealth? | Current EBITDA multiple of Nordhealth is 68.7x. |
| What is the current FCF of Nordhealth? | Nordhealth's last 12 months FCF is -$1.7M. |
| What is Nordhealth's FCF margin? | Nordhealth's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Nordhealth? | Current FCF multiple of Nordhealth is -1768.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
